Suppr超能文献

Oddi 括约肌松弛:胆石病的一个重要因素。

Sphincter of Oddi laxity: an important factor in hepatolithiasis.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Key Laboratory of Multi-Organ Transplantation of Ministry of Public Health, Key Laboratory of Organ Transplantation of Zhejiang Province, the First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2010 Feb 28;16(8):1014-8. doi: 10.3748/wjg.v16.i8.1014.

Abstract

AIM

To evaluate the importance of sphincter of Oddi laxity (SOL) in hepatolithiasis (HL).

METHODS

Subjects included 98 patients diagnosed with HL between 2002 and 2007. Detailed histories were taken and the subjects were monitored until July 2008. HL patients were divided into two groups: Group I included 45 patients with SOL, and Group II included 53 patients without. Recurrence and reoperation indices of both groups were calculated and compared.

RESULTS

The recurrence index was 0.135 in Group I and 0.018 in Group II (P < 0.001). The reoperation index was 0.070 in Group I and 0.010 in Group II (P < 0.001). The mean frequency of biliary operation was 2.07 in Group I and 1.21 in Group II (P = 0.001). Differences between the two groups are significant.

CONCLUSION

HL patients with SOL tend to have a higher risk of recurrence and a larger demand for reoperation than those without this condition.

摘要

目的

评估 Oddi 括约肌松弛(SOL)在胆石病(HL)中的重要性。

方法

纳入 2002 年至 2007 年间确诊为 HL 的 98 例患者。详细询问病史,并对患者进行监测,直至 2008 年 7 月。将 HL 患者分为两组:I 组 45 例存在 SOL,II 组 53 例不存在 SOL。比较两组患者的复发和再手术指数。

结果

I 组的复发指数为 0.135,II 组为 0.018(P < 0.001)。I 组的再手术指数为 0.070,II 组为 0.010(P < 0.001)。I 组的胆道手术平均频率为 2.07 次,II 组为 1.21 次(P = 0.001)。两组之间存在显著差异。

结论

与无 SOL 的 HL 患者相比,存在 SOL 的 HL 患者复发风险更高,再手术需求更大。

相似文献

1
Sphincter of Oddi laxity: an important factor in hepatolithiasis.
World J Gastroenterol. 2010 Feb 28;16(8):1014-8. doi: 10.3748/wjg.v16.i8.1014.
3
Oddi sphincter preserved cholangioplasty with hepatico-subcutaneous stoma for hepatolithiasis.
World J Gastroenterol. 2015 Dec 7;21(45):12865-72. doi: 10.3748/wjg.v21.i45.12865.
4
Is Oddi sphincterotomy an indication for hepatolithiasis?
Surg Endosc. 2009 Oct;23(10):2268-72. doi: 10.1007/s00464-008-0304-3. Epub 2009 Jan 28.
6
Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis.
World J Gastroenterol. 2015 Mar 28;21(12):3564-70. doi: 10.3748/wjg.v21.i12.3564.
7
Long-term outcomes of choledochoduodenostomy for hepatolithiasis.
Chin Med J (Engl). 2010 Jan 20;123(2):137-41.
8
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients.
Eur J Surg Oncol. 2014 May;40(5):567-575. doi: 10.1016/j.ejso.2013.12.006. Epub 2013 Dec 18.
9
Reappraisal of percutaneous transhepatic cholangioscopic lithotomy for primary hepatolithiasis.
Surg Endosc. 2005 Apr;19(4):505-9. doi: 10.1007/s00464-004-8125-5. Epub 2005 Feb 3.
10
Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction.
Gastrointest Endosc. 2003 Dec;58(6):875-8. doi: 10.1016/s0016-5107(03)02311-3.

引用本文的文献

1
Correlation analysis and recurrence evaluation system for patients with recurrent hepatolithiasis: a multicentre retrospective study.
Front Digit Health. 2024 Nov 27;6:1510674. doi: 10.3389/fdgth.2024.1510674. eCollection 2024.
2
Characterization of biliary and duodenal microbiota in patients with primary and recurrent choledocholithiasis.
Health Inf Sci Syst. 2024 Apr 4;12(1):29. doi: 10.1007/s13755-023-00267-2. eCollection 2024 Dec.
3
Hepatolithiasis: clinical series, review and current management strategy.
Turk J Surg. 2020 Dec 29;36(4):382-392. doi: 10.47717/turkjsurg.2020.4551. eCollection 2020 Dec.
5
Development of the Composition and Manufacturing Technology of a New Combined Drug: Lavaflam.
Turk J Pharm Sci. 2018 Dec;15(3):263-270. doi: 10.4274/tjps.79553. Epub 2018 Nov 20.
6
Surgical treatments for patients with recurrent bile duct stones and Oddis sphincter laxity.
Intractable Rare Dis Res. 2017 Aug;6(3):172-176. doi: 10.5582/irdr.2017.01053.
7
Preliminary study of a new pathological evolution-based clinical hepatolithiasis classification.
World J Gastroenterol. 2015 Feb 21;21(7):2169-77. doi: 10.3748/wjg.v21.i7.2169.
8
Laparoscopic hepaticoplasty using gallbladder as a subcutaneous tunnel for hepatolithiasis.
World J Gastroenterol. 2014 Mar 28;20(12):3350-5. doi: 10.3748/wjg.v20.i12.3350.

本文引用的文献

2
Selective sphincteroplasty of the papilla in cases at risk due to atypical anatomy.
World J Gastroenterol. 2007 Jun 14;13(22):3106-11. doi: 10.3748/wjg.v13.i22.3106.
3
Gallstone disease: Management of intrahepatic stones.
Best Pract Res Clin Gastroenterol. 2006;20(6):1117-37. doi: 10.1016/j.bpg.2006.05.010.
4
Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones.
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004890. doi: 10.1002/14651858.CD004890.pub2.
5
Treatment of non-endemic hepatolithiasis in a Western country. The role of hepatic resection.
Ann R Coll Surg Engl. 2006 Jul;88(4):383-9. doi: 10.1308/003588406X98711.
6
Surgical therapy for hepatolithiasis: a Western experience.
J Am Coll Surg. 2006 Feb;202(2):306-12. doi: 10.1016/j.jamcollsurg.2005.09.022. Epub 2005 Nov 21.
7
Normal sphincter of oddi motor function.
Curr Gastroenterol Rep. 2004 Apr;6(2):163-8. doi: 10.1007/s11894-004-0044-z.
8
[Dilatation of the papilla of Vater in the treatment of choledocholithiasis in selected patients].
Gastroenterol Hepatol. 2004 Jan;27(1):6-10. doi: 10.1016/s0210-5705(03)70437-3.
9
Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis.
Am J Gastroenterol. 2003 Dec;98(12):2655-62. doi: 10.1111/j.1572-0241.2003.08770.x.
10
[Current status of intrahepatic stones in Korea].
Korean J Gastroenterol. 2003 Aug;42(2):89-95.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验